Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update

NEXT STORY
Pardes Biosciences Appoints Deborah M. Autor, J.D. and Laura J. Hamill to Board of Directors
PREV STORY
TCR² Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in two leading causes of vision loss, potentially reducing treatment burden for patients

author_avatar
NASDAQ Market News

RedHill Biopharma to Present at the BIO-Europe 2017 Conference

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 26, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News

Global In-Vitro Diagnostics Market to 2025 – Market Size is Expected to Reach USD 98.99 Billion

Dublin, Nov. 16, 2018 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics (IVD) Market Size, ...

author_avatar
NASDAQ Market News